How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Minimally Invasive Biopsy Technique Market
- By Technique Type: Fine Needle Aspiration Biopsy (FNAB), Core Needle Biopsy (CNB), Vacuum-Assisted Biopsy (VAB), Endoscopic Biopsy, Image-Guided Biopsy
- By Guidance Modality: Ultrasound-Guided Biopsy, Computed Tomography (CT)-Guided Biopsy, Magnetic Resonance Imaging (MRI)-Guided Biopsy, Fluoroscopy-Guided Biopsy, Stereotactic Biopsy
- By Application Site: Breast Biopsy, Lung Biopsy, Liver Biopsy, Prostate Biopsy, Thyroid Biopsy, Lymph Node Biopsy
- By Device Type: Biopsy Needles, Biopsy Forceps, Biopsy Guns, Vacuum-Assisted Devices, Endoscopic Biopsy Devices
- By End User: Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers, Specialty Clinics
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Fine Needle Aspiration Biopsy (FNAB) leads By Technique Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 18 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 312 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.185 →
- 12 Company Profiles 18 players: SWOT & benchmarking p.193 →
Full report · locked preview
Everything inside the Minimally Invasive Biopsy Technique Market report
A complete, evidence-based study - 12 chapters and 131 sections covering market size, segmentation across 5 axes, regional analysis and 18 company profiles, forecast to 2033.
Segmentation covered
Technique Type 5
Guidance Modality 5
Application Site 6
Device Type 5
End User 4
Companies profiled
Hologic Inc.
Becton
Dickinson and Company (BD)
Medtronic plc
Siemens Healthineers
Canon Medical Systems Corporation
GE Healthcare
Philips Healthcare
Stryker Corporation
Olympus Corporation
Fujifilm Holdings Corporation
Cook Medical
+6 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
18 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Hologic Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Becton
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Dickinson and Company (BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Siemens Healthineers
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Canon Medical Systems Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →GE Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Philips Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Stryker Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Olympus Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Fujifilm Holdings Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Cook Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Baxter International Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →Boston Scientific Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.232 →C.R. Bard
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Inc. (now part of BD)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Hansen Medical
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.250 →Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.256 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$7,629M by 2033 · 6.0% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Fine Needle Aspiration Biopsy (FNAB)37.7
- Core Needle Biopsy (CNB)12.2
- Vacuum-Assisted Biopsy (VAB)18.8
- Endoscopic Biopsy19.8
- Image-Guided Biopsy11.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,578M → $2,794M · 7.4%
Europe$1,099M → $1,724M · 5.8%
Asia Pacific$1,004M → $1,695M · 6.8%
Latin America$621.4M → $1,032M · 6.5%
Middle East and Africa$478.0M → $737.4M · 5.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.962026
5.982027
5.992028
6.002029
6.022030
6.022031
6.032032
6.052033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Hologic Inc.25.4
- Becton13.9
- Dickinson and Company (BD)14.1
- Medtronic plc5.2
- Siemens Healthineers5.3
- Canon Medical Systems Corporation8.1
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Technique Type26.5%
Guidance Modality28.3%
Application Site17.0%
Device Type17.8%
End User10.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.0
- Europe21.6
- Asia Pacific21.2
- Latin America12.9
- Middle East and Africa9.2
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Hologic Inc. | 75 | 79 | 82 | 74 | 80 | 88 | 80 |
| Becton | 86 | 90 | 87 | 68 | 70 | 87 | 81 |
| Dickinson and Company (BD) | 65 | 83 | 87 | 69 | 82 | 70 | 76 |
| Medtronic plc | 57 | 65 | 72 | 80 | 57 | 69 | 67 |
| Siemens Healthineers | 63 | 55 | 58 | 58 | 61 | 54 | 58 |
| Canon Medical Systems Corporation | 57 | 61 | 51 | 70 | 62 | 66 | 61 |
| GE Healthcare | 56 | 60 | 42 | 41 | 42 | 50 | 49 |
| Philips Healthcare | 55 | 46 | 53 | 40 | 60 | 55 | 52 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Hologic Inc.
- Becton
- Dickinson and Company (BD)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Hologic Inc. | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Becton | ◐ | ◐ | ✓ | ◐ | ◐ | ✓ |
| Dickinson and Company (BD) | − | ✓ | ◐ | ✓ | ✓ | ✓ |
| Medtronic plc | − | ◐ | ◐ | ◐ | − | ◐ |
| Siemens Healthineers | − | ◐ | ◐ | ◐ | ◐ | − |
| Canon Medical Systems Corporation | ◐ | − | − | ◐ | − | − |
| GE Healthcare | − | ◐ | − | − | − | − |
| Philips Healthcare | ◐ | − | − | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Becton81
2Hologic Inc.80
3Dickinson and Company (BD)76
4Medtronic plc67
5Canon Medical Systems Corporation61
6Siemens Healthineers58
7Philips Healthcare52
8GE Healthcare49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Hologic Inc.Becton
Challenger2
Strong scale, closing on the leaders.
Dickinson and Company (BD)Medtronic plc
Contender2
Focused players with pockets of strength.
Siemens HealthineersCanon Medical Systems Corporation
Niche2
Specialists in a single segment or region.
GE HealthcarePhilips Healthcare
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Technique Type in North America, then scale across Minimally Invasive Biopsy Technique Market — a $432M beachhead inside a $7.98B market.
Beachhead (SOM)$432Mobtainable near-term
Serviceable (SAM)$2.99Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Fine Needle Aspiration Biopsy (FNAB)
Best fit — highest urgency & budget in Technique Type.
Economic buyer75 fit
Core Needle Biopsy (CNB)
Strong fit — clear ROI and a fast path to value.
End user65 fit
Vacuum-Assisted Biopsy (VAB)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Technique Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Guidance Modality & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application Site
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel26%
Digital / self-serve19%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Technique Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Minimally Invasive Biopsy Technique Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified26%
Evaluation12%
Closed-won7%
$11.3KCAC
$54KLTV
4.8:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Minimally Invasive Biopsy Technique Market is a durable-growth opportunity — $1.54B by 2033, compounding at 6.4%.
TAM · 2025$938Mtoday
TAM · 2033$1.54Bforecast
CAGR6.4%2027–2033
Cumulative$10.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.54BTotal addressable market
SAM$583MServiceable available market
SOM$100MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.4% CAGR
Demand compounds through 2033, outpacing GDP across Technique Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Technique Type moving from early to mainstream — durable secular demand.
Consolidation upside
18+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.54BLarge & growingTAM by 2033 at 6.4% CAGR
$583MServiceable nowreachable with today’s model
$100MBeachhead winobtainable near-term share
18+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.20BBear4.1% CAGR
$1.54BBase6.4% CAGR
$1.97BBull8.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Guidance Modality optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Minimally Invasive Biopsy Technique Market — a $1.63B market by 2033. Plan: grow share from 7.1% to 13.7%.
Market size · 2033$1.63Btotal addressable
Market CAGR11.6%2027–2033
Target share13.7%from 7.1% today
Revenue ambition$223Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.1% | 13.7% | Behind |
| Revenue | $114M | $223M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 33.5% | 44.4% | Behind |
| Customer retention | 89.9% | 96.5% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Technique Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Guidance Modality capability
A defensible second engine — invest in Guidance Modality to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Technique Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Guidance Modality
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $32M capacity & capability investment
- Greenlight bolt-on M&A in Guidance Modality
- Authorise North America expansion plan
- Fund R&D program for Technique Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskBehind
- Regulatory / policy changeAt risk
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Minimally Invasive Biopsy Technique Market conversation — a $1.79B market you can size, segment and defend in minutes.
Market size · 2033$1.79Btotal opportunity
Growth9.1%CAGR to 2033
Addressable buyers1,677+accounts in scope
Typical ROI5.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Technique Type
Goal Grow share in Technique Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.5×return on cost, year one
< 3 mopayback period
$61K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
18+players profiled in this market
Coverage includes
Hologic Inc.BectonDickinson and Company (BD)Medtronic plcSiemens HealthineersCanon Medical Systems CorporationGE HealthcarePhilips Healthcare+10 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Minimally Invasive Biopsy Technique Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Minimally Invasive Biopsy Technique Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Minimally Invasive Bariatric Surgery Equipment Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportMinimally Invasive Bariatric Surgery Device Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportMinimally Invasive Auxiliary Device Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportMinimally Invasive Anaesthesia Video Laryngoscopy Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportMinimal Invasive Surgery Devices Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportMinimal Invasive Spinal Devices Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportMinimal Invasive Cardiac Surgery Instruments Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportMini-invasive Surgery Forceps Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportMini Invasive Orthopaedic Surgery System Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportMini Interference Screw Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportMini Health Pot (Less than 1L) Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportMini Handheld Anesthesia Video Laryngoscope Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.